NEW HYDE PARK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)QUEENS-LONG ISLAND RENAL INSTITUTE, founded in 2009, is a community nonprofit in the Health Care sector that reported $5.0M in total revenue in fiscal year 2023. Expenses of $5.8M exceeded revenue, resulting in a 17% operating deficit.
TO ASSURE DIALYSIS PATIENTS OF THE FINEST QUALITY OF CARE, STATE-OF-THE-ART TECHNOLOGY AND UNCOMPROMISED DIGNITY, IN A COMFORTABLE SETTING.
QUEENS-LONG ISLAND RENAL INSTITUTE, INC. IS A CHARITABLE ORGANIZATION THAT RENDERS RENAL REPLACEMENT THERAPY SERVICES TO THOSE IN NEED. THE FACILITY IS LOCATED IN NEW HYDE PARK, NEW YORK AND PROVIDES...
QUEENS-LONG ISLAND RENAL INSTITUTE, INC. IS A CHARITABLE ORGANIZATION THAT RENDERS RENAL REPLACEMENT THERAPY SERVICES TO THOSE IN NEED. THE FACILITY IS LOCATED IN NEW HYDE PARK, NEW YORK AND PROVIDES IN-CENTER HEMODIALYSIS TO PATIENTS SUFFERING FROM END STAGE RENAL DISEASE (ESRD). TREATMENTS ARE PROVIDED TO PATIENTS IN FOUR DIFFERENT PATIENTS' SHIFTS, SIX DAYS PER WEEK. HEMODIALYSIS SERVICES ARE PROVIDED TO PATIENTS BY LICENSED AND TRAINED PROFESSIONALS IN ACCORDANCE WITH ALL STATE AND FEDERAL REGULATIONS. THE ORGANIZATION WILL BILL MEDICARE, MEDICAID AND OTHER THIRD PARTY PAYERS FOR SERVICES RENDERED TO PATIENTS. IN 2023 QUEENS-LONG ISLAND RENAL INSTITUTE SERVED 322 PATIENTS THROUGHOUT THE YEAR. IN 2023 QUEENS-LONG ISLAND RENAL INSTITUTE PROVIDED ITS HOME HEMODIALYSIS SERVICES. THE HOME HEMODIALYSIS PROGRAM SERVED 1 PATIENT.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $4,959,941 | $4,895,470 | +0.0% |
| Expenses | $5,821,799 | $5,292,684 | +0.1% |
| Net Income | $-861,858 | $-397,214 | +1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ROBERT STERLING | CHAIRMAN | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| NINA KOPPELMAN | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SHERYL SILVERSTEIN DMD | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JERRY LANDSBERG | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MICHAEL L DENHOFF | ASSISTANT SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| GARY GRANOFF | ASSISTANT TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| PHILIP KAPLAN | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| LEE CHARLES | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| LEONARD TANZER | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL ROSENBLUT | PRESIDENT/CEO | 5.50 |
Officer
|
$0 | $125,148 | $1,614,485 |
| ROBERT WERNER | CFO/EVP FOR OPERATIONS | 2.50 |
Officer
|
$0 | $98,538 | $746,761 |
| GERALDINE RAMOS | DIRECTOR OF PATIENT CARE SERVICES | 37.50 |
Highest
|
$139,200 | $51,145 | $190,345 |
| ROBERTO ALINDOGAN | HEMODIALYSIS RN | 37.50 |
Highest
|
$105,889 | $15,043 | $120,932 |
| KRISTIELYN SENIN | ASSISTANT NURSE MANAGER | 37.50 |
Highest
|
$109,792 | $24,991 | $134,783 |
| TAHIRA KHAN | RN - HOME HEMO COORDINATOR | 37.50 |
Highest
|
$113,268 | $12,644 | $125,912 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $4,959,941 | $5,821,799 | $2,549,561 | $-861,858 |
| 2022 | $4,895,470 | $5,292,684 | $3,365,776 | $-397,214 |
| 2021 | $4,980,097 | $5,280,984 | $4,125,753 | $-300,887 |
| 2020 | $5,080,369 | $5,139,230 | $4,700,332 | $-58,861 |
| 2019 | $5,550,762 | $5,296,261 | $3,865,502 | $254,501 |
| 2018 | $5,287,144 | $6,258,117 | $3,698,528 | $-970,973 |
Compare QUEENS-LONG ISLAND RENAL INSTITUTE with other nonprofits in New York and across the country.